We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+6.74%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$84.2M
AUM Growth
+$472K
(+0.56%)
Cap. Flow
+$1.64M
Cap. Flow
% of AUM
1.94%
Top 10 Holdings %
Top 10 Hldgs %
44.61%
Holding
75
New
3
Increased
26
Reduced
8
Closed
13
Top Buys
| 1 |
Sabre
SABR
|
+$1.72M |
| 2 |
World Kinect Corp
WKC
|
+$1.36M |
| 3 |
BRKL
Brookline Bancorp
BRKL
|
+$1.26M |
| 4 |
Alico
ALCO
|
+$641K |
| 5 |
OneSpan
OSPN
|
+$599K |
Top Sells
| 1 |
C3.ai
AI
|
+$1.34M |
| 2 |
CBAY
Cymabay Therapeutics
CBAY
|
+$1M |
| 3 |
B
Barrick Mining
B
|
+$945K |
| 4 |
Agnico Eagle Mines
AEM
|
+$780K |
| 5 |
Clear Secure
YOU
|
+$686K |
Sector Composition
| 1 | Healthcare | 36.45% |
| 2 | Industrials | 11.96% |
| 3 | Energy | 9.91% |
| 4 | Financials | 9.6% |
| 5 | Consumer Discretionary | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vornado Realty Trust
VNO
$7.51B
| $307K | 0.36% |
20,000
+10,000
| +100% | +$202K |
|
52
Edesa Biotech
EDSA
$63.3M
| $296K | 0.35% |
46,429
+1,747
| +4% | +$18.2K |
|
53
Lantern Pharma
LTRN
$37.5M
| $290K | 0.34% |
60,000
| – | – |
|
54
Nektar Therapeutics
NKTR
$2.28B
| $281K | 0.33% |
26,667
+18,334
| +220% | +$555K |
|
|
ADVM
55
DELISTED
Adverum Biotechnologies
ADVM
| $269K | 0.32% |
37,500
+27,500
| +275% | +$194K |
|
|
KRON
56
DELISTED
Kronos Bio
KRON
| $263K | 0.31% |
180,000
+150,000
| +500% | +$288K |
|
57
Femasys
FEMY
$9.06M
| $262K | 0.31% |
12,069
| – | – |
|
58
Park Hotels & Resorts
PK
$2.98B
| $247K | 0.29% |
+20,000
| New | +$263K |
|
59
Amneal Pharmaceuticals
AMRX
$5.76B
| $209K | 0.25% |
150,000
| – | – |
|
60
Smith Micro Software
SMSI
$14.3M
| $186K | 0.22% |
4,000
-625
| -14% | -$56.1K |
|
|
NEUE
61
DELISTED
NeueHealth
NEUE
| $110K | 0.13% |
6,250
| – | – |
|
|
NBSE
62
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $22K | 0.03% |
6,000
-11,500
| -66% | -$53.1K |
|
|
63
Agnico Eagle Mines
AEM
$68.1B
| – | – |
-15,000
| Closed | -$780K |
|
|
64
C3.ai
AI
$1.38B
| – | – |
-120,000
| Closed | -$1.34M |
|
65
Citigroup
C
$217B
| – | – |
-15,000
| Closed | -$678K |
|
|
CGAU
66
Centerra Gold
CGAU
$2.99B
| – | – |
-25,000
| Closed | -$130K |
|
67
CytomX Therapeutics
CTMX
$779M
| – | – |
-75,000
| Closed | -$120K |
|
|
B
68
Barrick Mining
B
$58.3B
| – | – |
-55,000
| Closed | -$945K |
|
69
inTEST
INTT
$169M
| – | – |
-55,000
| Closed | -$567K |
|
70
Organon & Co
OGN
$3.55B
| – | – |
-20,000
| Closed | -$559K |
|
71
Pan American Silver
PAAS
$17.6B
| – | – |
-15,000
| Closed | -$245K |
|
72
SSR Mining
SSRM
$5.32B
| – | – |
-15,000
| Closed | -$235K |
|
73
Warner Bros
WBD
$67.5B
| – | – |
-50,000
| Closed | -$474K |
|
|
74
Clear Secure
YOU
$5.59B
| – | – |
-25,000
| Closed | -$686K |
|
|
CBAY
75
DELISTED
Cymabay Therapeutics
CBAY
| – | – |
-160,000
| Closed | -$1M |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM
CM Management's Q1 2023 Portfolio in Review
As of Q1 2023, CM Management held 75 positions worth $84.2M, up 0.56% from $83.7M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
CM Management's Q1 2023 filing shows 3 new, 26 increased, 8 reduced and 13 closed positions. Its largest new stake was Sabre: 300,000 shares worth $1.29M. The largest sale was C3.ai, an estimated $1.34M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Industrials and Energy.
- CM Management's largest Q1 2023 buy was Sabre: 300,000 shares worth $1.29M.
- CM Management added most to Brookline Bancorp in Q1 2023, an estimated $1.26M increase.
- CM Management's biggest Q1 2023 reduction was Cytokinetics, cutting an estimated $612K.
- CM Management fully exited C3.ai in Q1 2023, selling an estimated $1.34M.
- CM Management's ten largest holdings make up 45% of its $84.2M portfolio in Q1 2023.
- CM Management opened 3 new positions and closed 13 in Q1 2023.
- CM Management's portfolio value rose 0.56% quarter-over-quarter to $84.2M.
Based on CM Management's 13F filing for Q1 2023, filed 8 May 2023.